Differential Characteristics of Two New Tumorigenic Cell Lines of Human Breast Carcinoma Origin
Overview
Authors
Affiliations
Permanent human tumor cell lines are an important tool for the study of breast cancer. Two new breast cancer cell lines (BrCa-MZ-01 and BrCa-MZ-02) were isolated from a solid tumor and a pleural effusion, respectively. One cell line was established from a medullary carcinoma, the other from a ductal carcinoma. These cells exhibit ultrastructural and immunohistochemical features of epithelial cells of mammary origin. Intermediate filament and cytokeratin typing showed a clear predominance of the simple-epithelial cytokeratins CK 8, CK 18 and CK 19, although the expression was reduced in comparison to the hormone receptor-positive reference cell lines MCF-7 and ZR-75-1. Both cell lines produced slow-growing tumors after subcutaneous (s.c.) transplantation of 1 x 10(7) viable tumor cells into nude mice. The cell line BrCa-MZ-01 expresses the estrogen and progesterone receptor, whereas the cell line BrCa-MZ-02 remains negative. Both cell lines are positive for secretion of platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta), whereas interleukin-6 (IL-6) is only secreted by the cell line BrCa-MZ-02.
Gilabert M, Launay S, Ginestier C, Bertucci F, Audebert S, Pophillat M PLoS One. 2014; 9(8):e104302.
PMID: 25144364 PMC: 4140711. DOI: 10.1371/journal.pone.0104302.
Loss, mutation and deregulation of L3MBTL4 in breast cancers.
Addou-Klouche L, Adelaide J, Finetti P, Cervera N, Ferrari A, Bekhouche I Mol Cancer. 2010; 9:213.
PMID: 20698951 PMC: 2933619. DOI: 10.1186/1476-4598-9-213.
Zabouo G, Imbert A, Jacquemier J, Finetti P, Moreau T, Esterni B Breast Cancer Res. 2009; 11(1):R1.
PMID: 19123925 PMC: 2687703. DOI: 10.1186/bcr2215.
Identification of genes for normalization of real-time RT-PCR data in breast carcinomas.
Lyng M, Laenkholm A, Pallisgaard N, Ditzel H BMC Cancer. 2008; 8:20.
PMID: 18211679 PMC: 2248196. DOI: 10.1186/1471-2407-8-20.
Letessier A, Mozziconacci M, Murati A, Juriens J, Adelaide J, Birnbaum D Br J Cancer. 2005; 92(2):382-8.
PMID: 15655561 PMC: 2361837. DOI: 10.1038/sj.bjc.6602228.